Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate cream versus placebo for prevention of radiation dermatitis in breast or chest wall radiotherapy
ISRCTN03885092Phase 3Completed
- Sponsor
- Lancashire Teaching Hospitals
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in radiodermatitis and breast cancer comparing Mometasone furoate cream with Placebo cream (2 arms). Primary endpoint: Change in visual skin assessment. Started Nov 2009; status: completed.
02
Drugs
mometasone
03
Conditions
radiodermatitisbreast cancer
Beyond the preview
Go deeper on ISRCTN03885092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03885092.